Figure 2
From: Impact of preoperative anemia on relapse and survival in breast cancer patients
LRFS, LNMFS, DMFS, RFS, and OS of patients with and without anemia. A. LRFS for patients with Hb ≥ 12 g/dL versus Hb < 12 g/dL. B. LNMFS for patients with Hb ≥12 g/dL versus Hb <12 g/dL. C. DMFS for patients with Hb ≥12 g/dL versus Hb <12 g/dL. D. RFS for patients with Hb ≥12 g/dL versus Hb <12 g/dL. E. OS for patients with Hb ≥12 g/dL versus Hb <12 g/dL.